Antiplatelet Therapy with Aspirin: From Clinical Trials to Practice

S. Goodnight
DOI: https://doi.org/10.1055/s-0038-1642711
1995-07-01
Thrombosis and Haemostasis
Abstract:Clinical trials of antiplatelet agents in patients with vascular disease have had a major impact on medical practice. Aspirin has been shown to be effective for both primary and secondary prevention of thrombotic events in the arterial circulation with a low risk of bleeding or other side effects (1-6). This discus­ sion will summarize recent advances in the use of antiplatelet therapy in the treatment of patients with vascular disease, with an emphasis on data from the clinical trials.
What problem does this paper attempt to address?